Jackson Benjamin — SEC insider filings
SEC reporting owner CIK 1779964. 32 insider filings on record with FilingPulse; latest filed 2026-09-11.
Transaction summary — filings shown
Covers all 32 filings on record, filed 2020-08-17 to 2026-09-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 8,000 shares, $9,600 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 22 legs across 19 filings — 101,859 shares, $547,463 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
- Largest priced transaction: sale of 12,041 shares @ $7.36 ($88,622) in SERA PROGNOSTICS, INC., filed 2025-01-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| SERA PROGNOSTICS, INC. (SERA) | General Counsel | 26 | 1 leg · 8,000 sh · $9,600 | 22 legs · 101,859 sh · $547,463 | 10 |
| MYRIAD GENETICS INC (MYGN) | Former E.V.P., General Counsel | 6 | — | — | 7 |
Insider filings — Jackson Benjamin
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-11 | 4 | SERA PROGNOSTICS, INC. (SERA) | Sale (S): 2,190 @ $2 | EDGAR |
| 2026-06-15 | 4 | SERA PROGNOSTICS, INC. (SERA) | Sale (S): 2,179 @ $2.01 | EDGAR |
| 2026-06-01 | 4 | SERA PROGNOSTICS, INC. (SERA) | Grant/award (A): 5,000 @ $1.84 | EDGAR |
| 2026-03-13 | 4 | SERA PROGNOSTICS, INC. (SERA) | Grant/award (A): 44,215 @ $0 · Grant/award (A): 68,550 (derivative) @ $0 | EDGAR |
| 2026-03-12 | 4 | SERA PROGNOSTICS, INC. (SERA) | Sale (S): 1,027 @ $2.04 | EDGAR |
| 2026-03-10 | 4 | SERA PROGNOSTICS, INC. (SERA) | Sale (S): 3,119 @ $1.96 | EDGAR |
| 2025-12-11 | 4 | SERA PROGNOSTICS, INC. (SERA) | Sale (S): 892 @ $3.31 | EDGAR |
| 2025-11-12 | 4 | SERA PROGNOSTICS, INC. (SERA) | Sale (S): 7,059 @ $2.62 | EDGAR |
| 2025-09-12 | 4 | SERA PROGNOSTICS, INC. (SERA) | Sale (S): 934 @ $3.13 | EDGAR |
| 2025-08-11 | 4 | SERA PROGNOSTICS, INC. (SERA) | Sale (S): 6,447 @ $2.54 | EDGAR |
| 2025-06-12 | 4 | SERA PROGNOSTICS, INC. (SERA) | Grant/award (A): 3,703 @ $1.33 | EDGAR |
| 2025-06-12 | 4 | SERA PROGNOSTICS, INC. (SERA) | Sale (S): 965 @ $1.48 | EDGAR |
| 2025-05-09 | 4 | SERA PROGNOSTICS, INC. (SERA) | Sale (S): 7,084 @ $2.44 | EDGAR |
| 2025-03-07 | 4 | SERA PROGNOSTICS, INC. (SERA) | Grant/award (A): 34,590 @ $0 · Sale (S): 2,285 @ $4.16 · Grant/award (A): 49,420 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | SERA PROGNOSTICS, INC. (SERA) | Sale (S): 5,915 @ $4.58 | EDGAR |
| 2025-01-14 | 4 | SERA PROGNOSTICS, INC. (SERA) | Sale (S): 12,041 @ $7.36 · Sale (S): 1,231 @ $8.05 · Sale (S): 7,912 @ $6.38 · Sale (S): 8,407 @ $6.20 | EDGAR |
| 2024-11-12 | 4 | SERA PROGNOSTICS, INC. (SERA) | Sale (S): 4,727 @ $7.32 | EDGAR |
| 2024-08-08 | 4 | SERA PROGNOSTICS, INC. (SERA) | Sale (S): 5,022 @ $7.42 | EDGAR |
| 2024-05-10 | 4 | SERA PROGNOSTICS, INC. (SERA) | Sale (S): 4,902 @ $9.59 | EDGAR |
| 2024-03-07 | 4 | SERA PROGNOSTICS, INC. (SERA) | Sale (S): 1,856 @ $9.02 | EDGAR |
| 2024-02-07 | 4 | SERA PROGNOSTICS, INC. (SERA) | Sale (S): 5,665 @ $8.03 | EDGAR |
| 2023-12-07 | 4 | SERA PROGNOSTICS, INC. (SERA) | Sale (S): 10,000 @ $5.22 | EDGAR |
| 2023-11-08 | 4 | SERA PROGNOSTICS, INC. (SERA) | Grant/award (A): 125,000 @ $0 | EDGAR |
| 2023-03-07 | 4 | SERA PROGNOSTICS, INC. (SERA) | Grant/award (A): 24,700 @ $0 · Grant/award (A): 39,100 (derivative) @ $0 | EDGAR |
| 2022-06-16 | 4 | SERA PROGNOSTICS, INC. (SERA) | Purchase (P): 8,000 @ $1.20 | EDGAR |
| 2022-03-25 | 4 | SERA PROGNOSTICS, INC. (SERA) | Grant/award (A): 60,345 (derivative) @ $0 | EDGAR |
| 2021-04-14 | 4 | MYRIAD GENETICS INC (MYGN) | Holdings only — no transactions reported | EDGAR |
| 2021-03-26 | 4 | MYRIAD GENETICS INC (MYGN) | Grant/award (A): 18,879 @ $0 | EDGAR |
| 2020-10-13 | 4 | MYRIAD GENETICS INC (MYGN) | Grant/award (A): 29,784 @ $0 | EDGAR |
| 2020-10-01 | 4 | MYRIAD GENETICS INC (MYGN) | Disposition to issuer (D): 416 @ $13.04 | EDGAR |
| 2020-09-28 | 4 | MYRIAD GENETICS INC (MYGN) | Disposition to issuer (D): 367 @ $12.44 · Disposition to issuer (D): 453 @ $12.44 · Disposition to issuer (D): 2,935 @ $12.44 | EDGAR |
| 2020-08-17 | 4 | MYRIAD GENETICS INC (MYGN) | Grant/award (A): 6,541 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1779964 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs